Tuesday, November 24, 2009, 3:48AM AEST - The Australian Stockmarket opens in 6 hours and 12 minutes.
To create a watchlist or portfolio of shares, Register

Unigene Laboratories Inc. (UGNE.OB)

3:09AM AEST: 0.98 USD   0.00 (0.00%)  
 MORE ON UGNE.OB 
Quotes
Charts
Technical Analysis
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials
ProfileGet Profile for:
Unigene Laboratories Inc.
81 Fulton Street
Boonton, NJ 07005
Phone: 973-265-1100
Fax: 973-335-0972
Web Site: http://www.unigene.com

 DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Other
Employees (last reported count):103

 REUTERS ABRIDGED BUSINESS SUMMARY 
Unigene Laboratories, Inc., a biopharmaceutical company, engages in the research, production, and delivery of peptides for medical use primarily in the United States. The company focuses on the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications, including nasal and oral calcitonin, and oral parathyroid hormone (PTH). It offers Fortical, a nasal calcitonin product for the treatment of postmenopausal osteoporosis. Unigene Laboratories has licensing agreements with GlaxoSmithKline to develop an oral formulation of an analog of PTH; Upsher-Smith Laboratories, Inc. to market Fortical; Novartis Pharma AG to manufacture calcitonin; and Shijiazhuang Pharmaceutical Group for research, development, and manufacture of recombinant salmon calcitonin and non-oral PTH. The company was founded in 1980 and is based in Boonton, New Jersey.
Key Statistics

 COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Unigene Laboratories Inc.



    View Financials

     OFFICERS 
     PayExercised
    Mr. Jay Levy , 85
    Co-Founder, Chairman, Treasurer and Assistant Sec.
    N/A N/A
    Dr. Warren P. Levy Ph.D., 57
    Co-Founder, Chief Exec. Officer, Pres
    N/A N/A
    Dr. Ronald S. Levy , 60
    Co-Founder, Exec. VP, Sec.
    N/A N/A
    Mr. William J. Steinhauer CPA, 54
    Principal Financial Officer, Principal Accounting Officer and VP of Fin.
    N/A N/A
    Dr. James P. Gilligan , 57
    VP of Product Devel.
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
    Get Profile for Another Symbol:
    Symbol Lookup
    Latest News7 Indices